45 cases on record
- Cases on record
- 45
- As claimant
- 42
- As respondent
- 3
- Patents held
- Not recorded
- Core tech
- A61K9/20 · C07D231/38 · A61K31/4152 · A61K31/506 · C07D401/14 · A61P35/00 · C07D239/69 · A61K9/19 · A61K47/34 · A61K47/26 · A61K31/397 · A61K31/138 · A61K45/06
| Case no. | Parties | Role | Court | Filed | Duration | Outcome |
|---|---|---|---|---|---|---|
| 25-225 | MSN Pharmaceuticals v. Novartis, AG | Defendant | U.S. Supreme Court | 22 Aug 2025 | 115 d | Petition Dismissed |
| 1:25-cv-00928 | Novartis, AG v. Teva Pharmaceutical Industries, Ltd. | Plaintiff | D. Del. | 24 Jul 2025 | 124 d | Voluntary dismissal |
| 2:25-cv-13193 | Novartis, AG v. Taro Pharmaceuticals | Plaintiff | D.N.J. | 11 Jul 2025 | 126 d | Voluntary dismissal |
| 1:25-cv-00800 | Novartis, AG v. Eugia Pharma Specialities, Ltd. | Plaintiff | D. Del. | 27 Jun 2025 | 18 d | Voluntary dismissal |
| 1:25-cv-00644 | Novartis, AG v. Zenara Pharma Private, Ltd. | Plaintiff | D. Del. | 23 May 2025 | 39 d | Voluntary dismissal |
| 1:25-cv-04282 | Novartis, AG v. Dr. Reddy's Laboratories, Ltd. | Plaintiff | D.N.J. | 15 May 2025 | 75 d | Voluntary dismissal |
| 1:25-cv-00578 | Novartis, AG v. Lupin Limited | Plaintiff | D. Del. | 9 May 2025 | 207 d | Voluntary dismissal |
| 25-1722 | Msn Pharmaceuticals, Inc. v. Novartis, AG | Defendant | Fed. Cir. | 1 May 2025 | 43 d | Voluntary dismissal |
| 25-1723 | Msn Pharmaceuticals, Inc. v. Novartis, AG | Defendant | Fed. Cir. | 1 May 2025 | 43 d | Voluntary dismissal |
| 1:25-cv-00350 | Novartis, AG v. Alembic | Plaintiff | D. Del. | 20 Mar 2025 | 8 d | Voluntary dismissal |
| 1:25-cv-00216 | Novartis, AG v. Cipla Limited | Plaintiff | D. Del. | 21 Feb 2025 | 18 d | Dismissed without Prejudice |
| 1:25-cv-00186 | Novartis, AG v. Cipla Limited | Plaintiff | D. Del. | 14 Feb 2025 | 234 d | Voluntary dismissal |
| 1:24-cv-01408 | Novartis, AG v. Umedica Laboratories Pvt., Ltd. | Plaintiff | D. Del. | 23 Dec 2024 | 10 d | Dismissed without Prejudice |
| 1:24-cv-01367 | Novartis, AG v. Natco Pharma, Ltd. | Plaintiff | D. Del. | 13 Dec 2024 | 139 d | Dismissed with Prejudice |
| 1:24-cv-01193 | Novartis, AG v. Msn Pharmaceuticals, Inc. | Plaintiff | D. Del. | 24 Oct 2024 | 103 d | Closed |
| 1:24-cv-01045 | Novartis, AG v. Lupin Limited | Plaintiff | D. Del. | 18 Sep 2024 | 69 d | Dismissed without Prejudice |
| 1:24-cv-01033 | Novartis, AG v. Natco Pharma, Ltd. | Plaintiff | D. Del. | 13 Sep 2024 | 230 d | Dismissed with Prejudice |
| 24-2209 | Novartis, AG v. Hetero USA, Inc. | Plaintiff | Fed. Cir. | 13 Aug 2024 | 247 d | Voluntary dismissal |
| 24-2210 | Novartis, AG v. Hetero USA, Inc. | Plaintiff | Fed. Cir. | 13 Aug 2024 | 247 d | Appeal Dismissed |
| 24-2211 | Novartis, AG v. Msn Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 13 Aug 2024 | 113 d | Appeal Dismissed |
| 24-2212 | Novartis, AG v. Msn Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 13 Aug 2024 | 113 d | Appeal Dismissed |
| 1:24-cv-00428 | Novartis, AG v. Teva Pharmaceutical Industries, Ltd. | Plaintiff | D. Del. | 4 Apr 2024 | 62 d | Dismissed without Prejudice |
| 1:23-cv-01449 | Novartis, AG v. Novugen Oncology SDN. BHD. | Plaintiff | D. Del. | 20 Dec 2023 | 75 d | Dismissed without Prejudice |
| 23-2317 | Novartis, AG v. Nanjing Noratech Pharmaceutical Co., Ltd. | Plaintiff | Fed. Cir. | 23 Aug 2023 | 566 d | Vacated and Remanded |
| 23-2319 | Novartis, AG v. Nanjing Noratech Pharmaceutical Co., Ltd. | Plaintiff | Fed. Cir. | 23 Aug 2023 | 566 d | Case Stayed |
| 23-2260 | Novartis, AG v. Mylan, NV | Plaintiff | Fed. Cir. | 9 Aug 2023 | 210 d | Appeal Dismissed |
| 23-2221 | Novartis, AG v. Hetero USA, Inc. | Plaintiff | Fed. Cir. | 31 Jul 2023 | 529 d | Appeal Dismissed in Part |
| 1:23-cv-00550 | Novartis, AG v. Msn Pharmaceuticals, Inc. | Plaintiff | D. Del. | 19 May 2023 | 627 d | Case Dismissed |
| 1:23-cv-00401 | Novartis, AG v. Nanjing Noratech Pharmaceutical Co., Ltd. | Plaintiff | D. Del. | 10 Apr 2023 | 799 d | Consent Judgment |
| 22-671 | Novartis, AG v. HEC Pharm Co., Ltd. | Plaintiff | U.S. Supreme Court | 18 Jan 2023 | 89 d | Petition Dismissed |
| 23-1334 | Novartis, AG v. Regeneron Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 5 Jan 2023 | 627 d | Unpatentable |
| 23-1113 | Novartis, AG v. Plexxikon, Inc. | Plaintiff | Fed. Cir. | 2 Nov 2022 | 420 d | Voluntary dismissal |
| 1:22-cv-01395 | Novartis, AG v. Alembic | Plaintiff | D. Del. | 24 Oct 2022 | 991 d | Judgment on the merits for Defendant |
| 1:22-cv-01045 | Novartis, AG v. Ingenus Pharmaceuticals, LLC | Plaintiff | D. Del. | 9 Aug 2022 | 356 d | Dismissed without Prejudice |
| 1:22-cv-00744 | Novartis, AG v. Accord Healthcare, Ltd. | Plaintiff | D. Del. | 6 Jun 2022 | 599 d | Case Settled |
| 1:21-cv-01794 | Novartis, AG v. Torrent Pharmaceuticals, Ltd. | Plaintiff | D. Del. | 22 Dec 2021 | 929 d | Consent Judgment |
| 1:21-cv-01760 | Novartis, AG v. Hetero USA, Inc. | Plaintiff | D. Del. | 16 Dec 2021 | 918 d | Consent Judgment |
| 1:21-cv-01330 | Novartis, AG v. Alkem Laboratories, Ltd. | Plaintiff | D. Del. | 20 Sep 2021 | 1022 d | Consent Judgment |
| 1:21-cv-00981 | Novartis, AG v. Msn Pharmaceuticals, Inc. | Plaintiff | D. Del. | 1 Jul 2021 | 1314 d | Dismissed with Prejudice |
| 1:21-cv-00870 | Novartis, AG v. Fresenius Kabi | Plaintiff | D. Del. | 17 Jun 2021 | 1328 d | Dismissed with Prejudice |
| 1:20-cv-01426 | Novartis, AG v. Aurobindo Pharma, Ltd. | Plaintiff | D. Del. | 23 Oct 2020 | 885 d | Consent Judgment |
| 1:20-cv-00074 | Novartis, AG v. Alembic | Plaintiff | D. Del. | 17 Jan 2020 | 1482 d | Consent Judgment |
| 1:19-cv-02053 | Novartis, AG v. Dr. Reddy's Laboratories, Ltd. | Plaintiff | D. Del. | 29 Oct 2019 | 2058 d | Case Dismissed |
| 1:19-cv-02021 | Novartis, AG v. Alembic | Plaintiff | D. Del. | 24 Oct 2019 | 1567 d | Consent Judgment |
| 1:19-cv-01979 | Novartis, AG v. Alkem Laboratories, Ltd. | Plaintiff | D. Del. | 17 Oct 2019 | 1786 d | Case Terminated |
Source: Patsnap Litigation Data. Cases naming Novartis, AG in the current snapshot.
Run this in Eureka
Patsnap Eureka
See what Novartis is protecting
Portfolio, claim scope and where its coverage is thin. Every answer cites the records behind it.
Analyse this portfolio10,000 free credits to start
Novartis
Map this dispute space
- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Disclaimer. This page indexes publicly available court docket data and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Coverage has limits. Records come from a snapshot and may lag live dockets. Sealed filings, amended complaints and post-closure motions may not be reflected, and a case missing from this list is not evidence that it does not exist. Counts on this page describe what the snapshot contains, nothing more.
No characterisation of any party. Appearing on this page means a party is named in a docket record. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, or that any party prevailed.